Oncology

More Procedures

CAR T-Cell Therapy

Phase 2 Study of the Oral Hypoxia-Inducible Factor 2a (HIF-2a) Inhibitor MK-6482 in Combination with Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma (ccRCC) Video

Phase 2 Study of the Oral Hypoxia-Inducible Factor 2a (HIF-2a) Inhibitor MK-6482 in Combination with Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

The Very Favorable Metastatic Renal Cell Carcinoma (mRCC) Risk Group: Data From the International Metastatic RCC Database Consortium (IMDC) Video

The Very Favorable Metastatic Renal Cell Carcinoma (mRCC) Risk Group: Data From the International Metastatic RCC Database Consortium (IMDC)

CAR T-cell and Transplant: Cellular Therapies for Malignant Disease Video

CAR T-cell and Transplant: Cellular Therapies for Malignant Disease

CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cell Immunotherapy For Adult B Cell Malignancies Video

CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cell Immunotherapy For Adult B Cell Malignancies

CAR T Cell Therapy for Autoimmune Blistering Disease | Research at Penn Video

CAR T Cell Therapy for Autoimmune Blistering Disease | Research at Penn

Chimeric Antigen Receptor T- Cells: Background, Toxicies, and Efficacy Video

Chimeric Antigen Receptor T- Cells: Background, Toxicies, and Efficacy